| (210) | Number of the EPO application | 18724754 |
| (220) | Filing date of the EPO application | 2018.04.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 52/2021, 2021.12.29 |
| (110) | EPO patent number | 3601283 |
| (11) | Number of the document | MD 3601283 T2 |
| (21) | Number of the application | e 2020 0142 |
| (71) | Name(s) of applicant(s), code of the country | Theravance Biopharma R&D IP, LLC, US; |
| (72) | Name(s) of inventor(s), code of the country | FATHEREE Paul R., US;
JIANG Lan, US;
MCKINNELL Robert Murray, US;
THALLADI Venkat R., US;
ZHANG Hao, US;
DABROS Marta, US;
NZEREM Jerry, US;
BENJAMIN Noah, US;
KLEINSCHEK Melanie A., US;
CRATER Glenn D., US; |
| (73) | Name(s) of owner(s), code of the country | Theravance Biopharma R&D IP, LLC, US; |
| (54) | Title of the invention | Fused imidazo-piperidine JAK inhibitor compound |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 471/04 (2006.01.01); A61K 31/437 (2006.01.01); A61P 11/00 (2006.01.01); A61P 17/00 (2006.01.01); A61P 27/02 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.03.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.05.31 |
| (30) | Priority | 201762492574 P, 2017.05.01, US |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2018/030148, 2018.04.30 |
| (87) | International publication | WO 2018/204238, 2018.11.08 |